An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma.
Cheng HeJing YangZheng JinYing ZhuWei HuLing-Feng ZengXiaocheng LiPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
The ALBI-AS grade is a novel predictor of survival for patients with BCLC stage B HCC.
Keyphrases